| 2101 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2102 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2103 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2104 |
Bone Marrow |
Allogeneic |
Other Immune System |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2105 |
Bone Marrow |
Allogeneic |
Other Immune System |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2106 |
Bone Marrow |
Allogeneic |
Primary Combined Severe Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2107 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2108 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2109 |
Bone Marrow |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2110 |
Bone Marrow |
Allogeneic |
Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2111 |
Bone Marrow |
Allogeneic |
Secondary Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2112 |
Bone Marrow |
Allogeneic |
Secondary Myelofibrosis Post Polycythemia Vera |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2113 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2114 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2115 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
31 |
| 2116 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2117 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2118 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2119 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2120 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
81 |
| 2121 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
29 |
| 2122 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2123 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2124 |
Bone Marrow |
Allogeneic |
Sickle Cell Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2125 |
Bone Marrow |
Allogeneic |
T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2126 |
Bone Marrow |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2127 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2128 |
Bone Marrow |
Allogeneic |
Very Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2129 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2130 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2131 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
67 |
| 2132 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2133 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2134 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2135 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
58 |
| 2136 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2137 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2138 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2139 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2140 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
52 |
| 2141 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2142 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2143 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2144 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2145 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2146 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
40 |
| 2147 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2148 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
35 |
| 2149 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2150 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2151 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
39 |
| 2152 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2153 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2154 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2155 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
19 |
| 2156 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2157 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2158 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2159 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
48 |
| 2160 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
47 |
| 2161 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2162 |
Apheresis |
Autologous |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2163 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2164 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2165 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2166 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2167 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
44 |
| 2168 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2169 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
31 |
| 2170 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
30 |
| 2171 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2172 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
72 |
| 2173 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
58 |
| 2174 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2175 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
32 |
| 2176 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2177 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2178 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2179 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2180 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2181 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2182 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2183 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2184 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2185 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2186 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2187 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2188 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2189 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
87 |
| 2190 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2191 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2192 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2193 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
46 |
| 2194 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2195 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
46 |
| 2196 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
33 |
| 2197 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2198 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2199 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
69 |
| 2200 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |